Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BIONEER Corp.
Swedish biotech Amniotics is developing a broad pipeline of unique stem cell therapeutics based on technology that is broadly applicable to major disease markets which should eventually draw the attention of big pharma players, its CEO tells Scrip.
- Antisense, Oligonucleotides
Drug Discovery Tools
- Other Names / Subsidiaries
- Bioneer Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.